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bstract
The present investigation was considered in arraying of antidiabetic and antioxidant activity from dietary flavonoid loaded fraction of Acan-
hophora  spicifera  (A.  spicifera, Family: Rhodomelaceae) on streptozotocin (STZ) induced oxidative stress rats. The testings were acted upon
ale rats, which were alienated into five groups: control group, diabetic group (single dose of 65 mg/kg, streptozotocin (STZ) i.p.), diabetic with
nsulin (6 IU), and diabetic with flavonoid rich fraction groups (FRF) at 50 and 100 mg/kg body weight, given orally for 21 days. The blood glucose
evel was determined at different week intermissions. The antioxidant consequences of FRF on STZ-induced diabetic rats were determined by the
stimations of the oxidative stress marker like malonyldialdehyde and antioxidant enzymes such as superoxide dismutase, catalase and glutathione
n tissue homogenates of heart, liver and kidney. FRF treatment of diabetic rats significantly (P  < 0.05) diminishes the blood glucose altitudes
o normal in contrast with diabetic rats. However, FRF administration, significantly decreased the malonyldialdehyde (MDA) and increased the
ctivities of superoxide dismutase (SOD), catalase (CAT) and glutathione levels (GSH) in diabetic rats. The outcome designates that FRF fraction
rom red algae A.  spicifera  was potent anti diabetic and antioxidant asset against STZ induced diabetes and oxidative tissue breakups.
 2016 Beijing Academy of Food Sciences. Production and hosting by Elsevier B.V. All rights reserved.
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.  Introduction
Diabetes mellitus is a metabolic ailment, as old as mankind
nd its occurrence is considered to be far above the ground at
ll over the world [1]. It is also a major root of disability and
ospitalization, results in a significant pecuniary burden [2]. The
anagement of diabetes mellitus is painstaking and thriving cure
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s yet to be discovered. The circumstances were primarily grim
n budding countries like India, where unprecedented economic
rowth has been accompanied with an unfortunate byproduct
f that prosperity in the form of diabetes [3,4]. It was sturdily
upported by greater than ever incidences in both experimental
nd clinical swot. It puts forward that oxidative stress caused by
yperglycemia, plays a foremost role in pathogenesis of diabetes
ellitus (DM). Diabetes is habitually accompanied by hyper-
lycemia with large amplification of reactive oxygen species
ROS) and impaired antioxidant defense co-ordination [5,6].
xidative stress, as an episode of oxidant factors over antioxi-
ant mechanisms, plays an innermost role in the pathogenesis
nd progression of diabetes and its complications. Hence, it is
ikely that a stuff known to reduce oxidative stress in  vivo  would
rim down the progression of cell damage in clinical diabetes. A
ietery flavonoids (abundant in plants, vegetables and Fruits) has
lsevier B.V. All rights reserved.
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een accounted to have a number of potentially beneficial effects
n both hindrance and management of oxygen-related diseases:
or example, the enhancement of glucose utilization in type II
iabetes [7] and reduction of the development of diabetic hitches
8]. Investigations in this particular region are now sparkling
nsights of potential benefits in diabetes. Seaweeds have tradi-
ionally been used as foodstuff and folk remedy for helminthes
nfections, gout and eczema, predominantly by coastal working
lass in several countries [9]. Recently, much attention has been
aid to the anticancer tumult of seaweeds due to their rich phyto-
onstituents and has reported that crude Swedes or their organic
xtracts have an influence on pancreatic -cells [10].
The seaweed Acanthophora  spicifera  (Family:
hodomelaceae, Ceramiales) is notorious red algae and
idely distributed in the Gulf of Mannar, Rameshwaram coast,
amilnadu, South India which is used as a food material,
osmetics, and fuel [11]. Besides, methanol extract of A.
picifera has been an evidence for anti-bacterial activity against
taphylococcus  aureus  and Bacillus  subtilis  [12]. The sulphated
garans are isolated from the aqueous extract of A.  spicifera  and
heir anti-viral chattels with their structure activity relationship
ere recorded [13]. Antioxidant properties of A.  spicifera  were
eliberate in different types of in  vitro  free radical scavenging
ssays [14]. Hence, present study was designed to extend
he current information on anti-diabetic folklore claim and
ntioxidant effect of A.  spicifera  and to determine its protective
ffects on rats having uncontrolled type I diabetes.
.  Materials  and  methods
.1.  Marine  algae  collection
The red algae, A.  spicifera  (Family: Rhodomelaceae, Cerami-
les) was collected from Mandapam, during the month of March,
014 from Rameswaram coast, Tamil Nadu, India [15]. It
as identified and authenticated by Dr. Krishnamurthy, Insti-
ute of algology, Annanagar, Chennai. The voucher specimen
SVCOP/14-125) was deposited in the Department Museum.
.2.  Preparation  of  the  ethanol  extract  and  separation
avonoids rich  fraction  from  Acanthophora  spicifera
Dried, milled A.  spicifera  (1 kg) was extracted through 5 l
f ethanol by means of soxhlet apparatus for 24 h. The extract
as filtered, and the filtrate was evaporated by a rotary vacuum
vaporator. The gain in yield of the menthol extract was found
o be 20.22% (w/w). The dried ethanol extract was suspended
n water and assorted with n-hexane in a separating funnel and
-hexane portion was discarded after separation. To the aqueous
ortion, dichloromethane was added and the dichloromethane
ortion was discarded after separation and the aqueous portion
as collected and further extracted with ethyl acetate. The ethyl
cetate portion was collected and it was allowed to dry for com-
lete removal of solvent by a rotary vacuum evaporator. The
ield of the ethyl acetate fraction was 2.45% (w/w). The ethyl
cetate fraction was subjected to qualitative chemical test and
hin layer chromatography (TLC) studies and showed positive
est for flavonoids.
2
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.3.  Estimation  of  total  phenol  content  in  FRF
Total phenolic content was estimated with Folin–Ciocalteu
olorimetric method described previously [16,17] with a little
odification. Briefly, the appropriate dilutions of the FRF were
xidized with 0.2 N Folin–Ciocalteu reagents and then the reac-
ion was neutralized with saturated sodium carbonate (75 g/l).
he absorbance of the resulting blue color was measured at
60 nm after incubation for 2 h at 23 ◦C. Quantification was done
n the basis of the standard curve of Gallic acid. Results were
xpressed as grams of gallic acid equivalent (GAE) per 100 g of
ry weight (DW).
.4.  Animals
Healthy adult Wistar rats of either sex, weighing 200–250 g,
ere used. The animal room was maintained at 22 ±  5 ◦C with
 daily light-dark cycle (06:00–18:00 light) and humidity about
0%–60%. Animals were given food and water ad  libitum. All
he studies were conducted in accordance with the Animal Eth-
cal Committee (SVCOP/02/2015/SV0026).
.5.  Acute  oral  toxicity  study
Acute toxicity was carried out according to the Organiza-
ion for Economic Co-operation and Development guidelines
OECD 423). Two groups of control rats (n  = 3 in each group)
ere given FRF separately 2000 mg/kg p.o. as single dose. After
ral administration animals were observed continuously for 2 h
or beneath profiles like alertness, restlessness, irritability, fear-
ulness spontaneous activity, reactivity, touch response, pain
esponse, defecation and urination. After the stage of 24 and
2 h, animals were observed for signs of lethality or for death.
.6.  Evaluation  of  oral  glucose  tolerance  test  (OGTT)
Initial screening of fractions for hypoglycemic activity was
arried out in normal healthy rats by conducting OGTT. The
GTT was performed for two different doses of FRF (50 and
00 mg/kg bodyweight per orally) and blood glucose level was
easured by one touch glucometer (Accu-check, India). The
lucose level was measured at the intervals of 0, 30, 60, 90 and
20 min after the administration of test samples [18].
.7.  Induction  of  diabetes  in  rats
Diabetes was induced by a single intra-peritoneal injection of
ewly prepared streptozotocin (65 mg/kg) in 0.1 mol/L citrate
uffer (pH 4.5) to overnight fasted rats. In order to prevent initial
rug induced hypoglycemia, STZ injected animals were given
ith 5% glucose water for 24 h. After three days of STZ adminis-
ration, rats were divided according to their fasting blood glucose
evels which showed >300 mg/dl. The animals did not show the
bove blood glucose range is excluded from the study [19]..8.  Experimental  design  and  drug  administration
Rats were divided in to four groups of six rats in each group.
roup I (normal animals) treated with only vehicle, 0.3% CMC
e and
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diabetic rats
Fig. 2 illustrates the levels of glucose in diabetic rats, which
is measured at various time intervals after STZ treatment. TheL. Vuppalapati et al. / Food Scienc
v/v). Group II animals are diabetic rats treated with 0.3% CMC.
roup III animals are diabetic animals treated with Insulin (6 IU)
nd Group IV–V rat are diabetic animals treated with FRF (50
nd 100 mg/kg, per oral) on the 3rd day after the induction of
iabetes. Rats were fasted overnight and blood samples were
ollected from the tail vein on the 3rd day of STZ treatment
rior to and at 7th, 14th and 21st day after the administration of
he FRF.
.9.  Estimation  of  blood  glucose  and  proteins
Blood glucose was determined using one touch instant glu-
ometer by using glucose strips. At the end of the experiment,
nimals (n  = 3/group) are sacrificed by euthanasia, tissues like
eart, liver and kidney were isolated and minced, homogenized
ith a polytron homogenizer using 20 mmol/L phosphate buffer
olution (pH 7.4). The homogenate was centrifuged at 1000 ×  g
or 8 min at 4 ◦C. The supernatant obtained by centrifugation
as used for in  vitro  protein analysis [20].
.10.  Estimation  of  glycosylated  hemoglobin
Glycosylated hemoglobin was estimated by the method of
ross et al. [21]. To the erythrocytes (0.5 mL) collected from
hole EDTA blood, 0.125 mL of distilled water and 0.125 mL
f carbon tetrachloride were added, mixed well and centrifuged.
he supernatant hemolysate was separated and its hemoglobin
oncentration was adjusted to 10% with distilled water. To 2 mL
f hemolysate, 1 mL of 0.3 N oxalic acid was added into test
ubes and heated at 100 ◦C in a water bath for 60 min. After
ooling, 1 mL of 40% TCA was added, shaken well and cen-
rifuged. To 2 mL of supernatant was pipetted out into another
et of test tubes, 0.5 mL of 0.05 mol/L TBA was added and incu-
ated at 37 ◦C for 40 min. A blank with 2 mL of distilled water
as treated similarly. The resulting yellowish color was read on
 spectrophotometer at 443 nm. Concentration of HbA1c was
alculated on the assumption that 1% HbA1c corresponds to
n absorbency of 0.029 at 443 nm (experimentally determined
illimolar extinction co-efficient for TBA-5 hydroxymethyl fur-
ural adduct is 26 at 443 nm). Hemoglobin in RBC (g%) was
stimated by cyanmethemoglobin method.
.11.  Biochemical  or  antioxidant  analysis  of  heart,  liver
nd kidney  homogenates
After the collection of blood samples, the rats were sacrificed.
eart, liver and kidney were excised, rinsed in ice cold normal
aline followed by ice-cold 10% KCl solution, blotted, dried
nd weighed. 10% (w/v) organs were homogenated separately
n ice-cold KCl solution and centrifuged at 1500 r per minute
or 15 min at 4◦ C. The supernatant thus obtained were used
or the estimation of superoxide dismutase (SOD) [22], catalase
CAT) [23], glutathione (GSH) [24], thio-barbituric acid reactive
ubstances (TBARS) [25].
.  Histopathology  Studies
Subsequent to blood sample for the biochemical analysis,
he animals were forfeit, quickly dissected. A tiny portion of
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ancreases was engaged and fixed in 10% formalin. The spec-
men was dehydrated in ascending grades of ethanol, clean in
ylene and entrenched in paraffin wax. Segments were of 6 m
n thickness stained with haematoxylin and eosin and subjected
o microscopic inspections.
.1.  Statistical  analysis
Data were expressed as mean ±  SEM. The data in each group
nalyzed by two way ANOVA followed by post hoc analysis
 Dunnett’s comparison tests using PRISM PAD 5 statistical
oftware, USA. Probability level P  < 0.05 and P < 0.01 were
onsidered as significant.
.  Results
.1.  Acute  toxicity  study
In acute toxicity tests, rats are fed with FRF orally 2000 mg/kg
ody weight, did not shown any behavioral abnormality and
ortality. Animals are well tolerated and were not reported toxic
o the dose of 2000 mg/kg body weight. The 1/20th (100 mg/kg)
nd 1/40th (50 mg/kg) dose was considered for further pharma-
ological evaluation. The experiments and dose fixations were
arefully designed in order to minimize the animal’s usage.
.2.  Effect  of FRF  fraction  on  oral  glucose  tolerance  test  in
xperimental  rats
In OGTT (Fig. 1) investigation group I served as normal con-
rol, group II served as FRF 50 mg/kg and group III served as
RF 100 mg/kg body weight. The blood levels of glucose were
emonstrated the significant change after oral administration of
lucose solution. Dose dependent blood glucose reduction was
bserved in rats (group II and group III) after treatment of FRF
0 and 100 mg/kg at 60, 90 and 120 min.
.3.  Effect  of FRF  on  blood  glucose  levels  in  STZ  treatedig. 1. Effect of FRF on blood serum glucose level (OGTT) on glucose loaded
ats. *P < 0.05, control vs group II (FRF 100 mg/kg); **P < 0.05, group I (con-
rol) vs group II (FRF 50 mg/kg) and III (FRF 50 mg/kg) (one-way ANOVA –
ollowed by Dunnett’s post-test).
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Fig. 2. Effect of FRF and insulin on blood glucose level of STZ treated diabetic
rats. **P  < 0.01, diabetic control vs control group; @@P < 0.01, insulin treated
g
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Fig. 4. Effect of FRF and insulin on SOD levels in heart, liver and kidney of STZ
treated diabetic rats. ##P < 0.01, diabetic control vs control group; @@P < 0.01,
F
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troup vs diabetic control; ##FRF treated group vs diabetic control (one-way
NOVA – followed by Dunnett’s post-test).
lood glucose level was increased several fold to more than
00 mg/dl in STZ treated rats which are compared to non dia-
etic control rats (average 101.8 mg/dl) indicating diabetes in
TZ treated animal group. By administration of insulin, it was
bserved that appreciably (P  < 0.05) decrease in blood glucose
evel measured at 3rd, 7th, 14th and 21st day to STZ treatment
nimals. Oral administration of FRF (50 and 100 mg/kg) to dia-
etic animals significantly lower elevated blood glucose levels
rom 7th to 21st day as analyzed by Tukey’s multiple comparison
ith the diabetic group alone.
.4.  Effect  of  FRF  on  HbA1c levelsAs shown in Fig. 3, there was a significant increase in the
evels of HbA1c in diabetic animals due to the state of disorder.
ig. 3. Effect of FRF on Glycosilated hemoglobin. ##P < 0.0001, control vs
iabetic control; **P  < 0.0001, insulin treated and FRF treated diabetic group
s diabetic control (one-way ANOVA – followed by Dunnett’s post-test).
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LRF treated group vs diabetic control (one-way ANOVA – followed by Dunnett’s
ost-test).
owever, after administration of FRF (50 and 100 mg/kg) sig-
ificantly reversed the HbA1c levels to a normal control group.
t was worth noticing that, at the end of the study all the results
ere close to insulin treated group.
.5.  Effect  of  FRF  on  SOD  levels  in  Heart,  liver  and
idneys of  STZ  treated  rats
The effect of insulin and FRF on SOD levels in rat heart,
iver and kidneys were shown in Fig. 4. In the diabetic group,
epletion of SOD level was observed in all organs compared to
hat of the control animal group. Administration of FRF 50 and
00 mg/kg significantly (P  < 0.05) elevated the SOD levels in all
rgans tested in diabetic rats as compared to the diabetic group
lone. In insulin treated group, an increase in SOD levels was
bserved, which is statistically insignificant.
.6.  Effect  of  FRF  on  catalase  levels  in  heart,  liver  and
idneys of  STZ  treated  rats
Catalase (CAT) activity in the heart, liver and kidney of dia-
etic rat was shown in Fig. 5. Significant decrease (P  < 0.05) in
atalase activity was noted in STZ treated diabetic rats as com-
ared to that of control non-diabetic animals. Administration
f FRF 50 and 100 mg/kg and insulin, significantly reverse the
ecreased catalase activity in liver and kidney tissues. More-
ver, there is no significant effect was observed in heart tissue
s compared to STZ treated diabetic group alone.
.7.  Effect  of  FRF  on  LPO  levels  in  heart,  liver  and  kidneys
f STZ  treated  ratsThe effect of insulin and FRF in TBARS levels was rep-
esented in Fig. 6. In diabetic rats, an increase in the level of
PO marker malonyldialdehyde (MDA) was observed in vital
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Fig. 5. Effect of FRF and insulin on catalase (CAT) levels in heart, liver and
kidney of STZ treated diabetic rats. *P < 0.05, diabetic control vs control group;
@,#P < 0.05, FRF treated group vs diabetic control (one-way ANOVA – followed
by Dunnett’s post-test).
Fig. 6. Effect of FRF and insulin on malonylaldehyde (TBARS) levels in heart,
liver and kidney of STZ treated diabetic rats. *P < 0.05, diabetic control vs con-
trol group; #P < 0.05, insulin treated diabetic group vs diabetic control; #P < 0.05,
FRF treated diabetic group vs diabetic control (one-way ANOVA – followed by
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Fig. 7. Effect of FRF and insulin on GSH levels in heart, liver and kidney of STZ
treated diabetic rats. ***P < 0.001, diabetic control vs control group; ##P < 0.05,
FRF treated diabetic group vs diabetic control (one-way ANOVA-followed by
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B.W. exhibited significant effect on serum blood glucose lev-
els at 30, 60, 90, 120 min which is compared to control. Theunnett’s post-test).
issues. The amount of MDA formed inside liver is very high
830 ±  35 mol/mg of protein) was higher as compared to con-
rol group liver (210 ±  45 mol/mg of protein). Treatment with
RF (50 and 100 mg/kg) and insulin was significantly (P  < 0.05)
owered the MDA levels in all organs as compared to diabetic
roup.
.8.  Effect  of  FRF  on  GSH  levels  in  Heart,  liver  and
idneys of  STZ  treated  rats
The effect of insulin and FRF in GSH levels was represented
n Fig. 7. In diabetic rats, significant (P  < 0.001) decrease in the
evel of GSH was observed in all tissues. Treatment with FRF
50 and 100 mg/kg) was significantly (P  < 0.01) increased GSH
evels in all organs as compared to diabetic group. tunnett’s post-test).
.  Histopathology  Reports
FRF fraction showed the marked results on the pancreas
hich was compared to that of insulin treated groups. In the
ontrol group, Islets of Langerhans were scattered in the pan-
reatic tissue by varying in size at the same lobule. It was
bserved that no evidence of inflammatory cells with less intra-
ellular spaces (Fig. 8A). But in case of diabetic control group
Fig. 8B) elicits disarray of cell into surrounding exocrine tis-
ues. All these conditions were seemed to return back to normal
Fig. 8D, E) by reducing the intracellular space and retur-
ing of islets in to exact location after the treatment of FRF
ractions.
.  Discussion
The present study highlights the defensive outcome of
avonoid rich fraction (FRF) from the marine source A.  spi-
ifera, red algae in STZ induced oxidative stress rats. The effect
f FRF on blood glucose, tissue antioxidants and oxidative stress
arkers were considered in STZ induced rat model. This metic-
lous model of STZ-induced hyperglycemia has been described
s a useful experimental model to study the activity of anti-
iabetic agents with or without insulin [26,27]. Our results
ave been an evidence for intraperitoneal administration of STZ
65 mg/kg) effectively induced hyperglycemia in normal fasted
ats as compared with control saline treated rats. The elevated
evel of blood glucose could be due to destruction of pancre-
tic -cells by STZ [28]. The capacity of FRF to decrease the
levated blood sugar to normal glycemic level is an essential
rigger for the liver to revert to its normal homeostasis during
xperimental diabetes. In OGTT results, FRF 50 and 100 mg/kgest results revealed that FRF 100 mg/kg has shown maximum
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7ig. 8. Photomicrograph of pancreatic tissues stained by hematoxylin and eos
0 mg/kg treated group; (E) FRF 100 mg/kg treated group.
ntihyperglycemic activity in all time intervals than 50 mg/kg.
urther, results confirmed that flavonoid fractions from the sea-
eed of A.  spicifera  controlled hyperglycemia by significantly
educing blood glucose level in diabetic rats. FRF extracts (50
nd 100 mg/kg) fall short to show anti-diabetic effect after dia-
etic onset at 48th hrs. However FRF significantly decreased
lood glucose levels at 7th and 21st day after onset of diabetes.
n earlier reports, red algae A.  Spicifera  contains various phyto-
hemicals like steroids, flavonoids, and proteins [29] which
osses antiviral and antibacterial activities [12,13]. In additional,
mplified heights of HbA1c in diabetic rats indicated the inci-
ence of glycosylation due to hyperglycemia. Administration of
RF extracts (50 and 100 mg/kg) and insulin to the diabetic rats
ignificantly reduced HbA1c levels. The rationalization behind
his was assumed to be an improvement in insulin secretion. This
uggested that FRF extracts (50 and 100 mg/kg) might have the
otential to reorganize the progress of diabetes with connected
itches.
This is the first biochemical investigation that the organ
rotective effect of FRF from seaweed of A.  spicifera  in strep-
ozotocin induced oxidative stress diabetic animals. There is an
nderstandable relationship between hyperglycemia and active
xygen/nitrogen species in experimental and clinical types of
iabetes [30]. Amassing of reactive oxygen species (ROS) due
o oxidative stress is also instrumental in the expression of
ell death, as ROS can easily react and oxidize vital cellular
omponents such as lipids, proteins and DNA [31]. The vital
rgans like heart, liver, and kidney are particularly suscepti-
le to the effects of ROS due to its poly-unsaturated integrity
nd modest antioxidant defense [32]. Experimental studies have
ndicated the potential usefulness of exogenous antioxidants for
revention and treatment of diabetes mellitus. A plant derived
nti-oxidant treatment has been reported to reduce the devel-
pment of diabetic complication such as, retinopathy, cataract
ormation, neuropathy, vascular complication and nephropathy
y increasing the antioxidant status in insulin dependent and
on-insulin dependent tissues [33].
In the present study, there is apparently no compensatory
echanism in visceral organs in order to overcome STZ induced
xidative stress. Reduced activities of SOD and CAT in liver, kid-
ey and heart have been observed during diabetes. SOD is vital
efence enzyme which catalyses the dismutation of superoxide
adicals [34]. CAT is a hemeprotein which catalyses the reduc-
ion of hydrogen peroxides and protects the tissues from highly
eactive hydroxyl radicals [35]. Therefore, fall in the activity of
a
i(A) control; (B) STZ treated diabetic rats; (C) insulin treated group; (D) FRF
hese enzymes (SOD, CAT) may consequence in a number of
eleterious effects due to the accumulation of superoxide anion
adicals and hydrogen peroxides. Administration of FRF sig-
ificantly increased SOD levels in all the vital organs tested.
owever, increased in CAT level was only observed in liver and
idney but not in heart tissue of the diabetic rats. From the present
tudy, it was quite interesting to observe that, increased lipid per-
xidation in vital organs of rats exposed to hyperglycemia and its
ttenuation by the control of hyperglycemia with FRF treatment.
t strongly suggests the protective role of the FRF, which could
e due to the antioxidative effect of flavonoids present in the red
lgae, which acts as strong superoxide radical scavengers and
inglet oxygen quenchers. Earlier report on STZ treated animals
ith insulin treatment significantly reverse SOD and CAT lev-
ls in the heart and kidneys of the diabetic rats [36]. The effect
f insulin in SOD, CAT and TBARS level was in accordance
ith the earlier reports [37,38]. It is interesting to observe that
igh dose of FRF significantly increases the GSH level in STZ
reated rat vital organs. Cellular Glutathione pool enzymes have
 key role in enzymatic defense systems and acts on peroxi-
es (H2O2, lipid or organic peroxides) to remove them. In the
resent investigation, it was observed that FRF treatment could
ffectively increase the activity of GSH and other antioxidant
nzymes. The cellular GSH pool is mainly maintained by the
xidation of GSH and regeneration of reduced GSH by GSH-
eroxidase and GSSG-reductase enzymes respectively. Under
xidative stress condition, increased oxidation of GSH by GSH-
x and decreased regeneration of GSH by GSSG-reductase have
een implicated as the main reason for the reduced level of
SH. Histopathology study also props up our output. STZ was
upposed to annihilate pancreas partially. Diabetic rats showed
ondensed (or) reduced islet cells, which were restored to nor-
al upon treatment with the FRF (50 and 100 mg/kg) of A.
picifera. No such variation was found in normal rats. These
esults indicate that the FRF fraction of red algae A.  spicifera
howed significant pro protection against the oxidative damage
nduced by STZ in liver and kidney of rats. FRF may act as pro-
ective agents against STZ induced liver and kidney damage and
ree radical scavenger agent.
.  ConclusionOur study confirmed that FRF extracts had an outstanding
ntidiabetic effect, which could be elucidated, at least in part, by
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